STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
24
13F, latest reported quarter
Conversions, 180 days
8
Codes C/M, not in net · $871.7K priced
What the filings say about TRT
Insiders, 180 days
-$2.5M net sold
3 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$573.5K
1 notice
Trio-tech International insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, TRIO-TECH INTERNATIONAL insiders sold a net $2.5M of stock across 56 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
25 earlier Form 4 trades (code P or S) here by this insider (25 sales), the last on Jun 18, 2026.
The trade is 3.6% of the 140,094 shares held after it.
1 other insider sold within 30 days.
24 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director ADELMAN JASON T sold about $74.4K of TRT on Jun 19, 2026; 1 other insider sold within 30 days and 24 funds added in the latest 13F quarter.
24 earlier Form 4 trades (code P or S) here by this insider (24 sales), the last on May 19, 2026.
The trade is 3.4% of the 145,094 shares held after it.
1 other insider sold within 30 days.
24 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director ADELMAN JASON T sold about $79.2K of TRT on Jun 18, 2026; 1 other insider sold within 30 days and 24 funds added in the latest 13F quarter.
21 earlier Form 4 trades (code P or S) here by this insider (21 sales), the last on Apr 20, 2026.
The trade is 13.1% of the 131,044 shares held after it.
2 other insiders sold within 30 days.
24 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director TING HOCK MING sold about $286.4K of TRT on May 26, 2026; 2 other insiders sold within 30 days and 24 funds added in the latest 13F quarter.
22 earlier Form 4 trades (code P or S) here by this insider (22 sales), the last on May 18, 2026.
The trade is 20.5% of the 45,617 shares held after it.
2 other insiders sold within 30 days.
24 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director ADELMAN JASON T sold about $131.1K of TRT on May 19, 2026; 2 other insiders sold within 30 days and 24 funds added in the latest 13F quarter.
22 earlier Form 4 trades (code P or S) here by this insider (22 sales), the last on May 18, 2026.
The trade is 14.0% of the 40,000 shares held after it.
2 other insiders sold within 30 days.
24 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director ADELMAN JASON T sold about $78.5K of TRT on May 19, 2026; 2 other insiders sold within 30 days and 24 funds added in the latest 13F quarter.
56 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
TRT planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
HOROWITZ RICHARD M
Filed 2026-09-28
$573.5K
HOROWITZ RICHARD M
Filed 2026-06-22
$454.2K
TRT mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Ultra-Small Company Market Fund
$506.4K position · as of 2026-06-30
0.3%
Omni Small-Cap Value Fund
$290.8K position · as of 2026-06-30
0.0%
U.S. MICRO CAP PORTFOLIO
$284.8K position · as of 2026-07-31
0.0%
Dimensional US Vector Equity ETF
$19.2K position · as of 2026-07-31
0.0%
U.S. SMALL CAP VALUE PORTFOLIO
$632.0K position · as of 2026-07-31
0.0%
Dimensional VA U.S. Targeted Value Portfolio
$14.3K position · as of 2026-07-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$520.0K
$456.9K
$208.4K
+4%
n/a
2023
$535.7K
$609.1K
$221.6K
+16%
n/a
2022
$542.8K
$558.1K
$156.5K
-8%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $2.5M sold by insiders over 180 days, 24 funds added last quarter, $573.5K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$62.6M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM TRT
FY Jun 2026
$62.6M
FY Jun 2025
$36.5M
FY Jun 2024
$42.3M
FY Jun 2023
$43.2M
FY Jun 2022
$44.1M
Jun 2026
$14.9M
Mar 2026
$16.5M
Dec 2025
$15.6M
Sep 2025
$15.5M
Jun 2025
$10.7M
Mar 2025
$7.4M
Dec 2024
$8.6M
Sep 2024
$9.8M
At each fiscal year end
Single quarter
Net margin, TTM
-0.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM TRT
FY Jun 2026
-0.1%
FY Jun 2025
-0.1%
FY Jun 2024
+2.5%
FY Jun 2023
+3.6%
FY Jun 2022
+5.4%
Jun 2026
-1.3%
Mar 2026
-0.2%
Dec 2025
+0.8%
Sep 2025
+0.5%
Jun 2025
+1.7%
Mar 2025
-6.7%
Dec 2024
+5.9%
Sep 2024
-2.4%
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM TRT
FY Jun 2026
$1.7M
FY Jun 2025
-$596.0K
FY Jun 2024
$2.2M
FY Jun 2023
$3.6M
FY Jun 2022
$655.0K
Jun 2026
$244.0K
Mar 2026
$707.0K
Dec 2025
-$152.0K
Sep 2025
$887.0K
Jun 2025
-$1.2M
Mar 2025
$625.0K
Dec 2024
$1.9M
Sep 2024
-$1.9M
At each fiscal year end
Single quarter
Debt to equity
0.01x
LongTermDebt as filed 2026-06-30 (includes the current portion); equity 2026-06-30
Debt to equity TRT
FY Jun 2026
0.01x
FY Jun 2025
0.02x
FY Jun 2024
0.03x
FY Jun 2023
0.05x
FY Jun 2022
0.05x
Jun 2026
0.01x
Mar 2026
0.02x
Dec 2025
0.02x
Sep 2025
0.02x
Jun 2025
0.02x
Mar 2025
0.02x
Dec 2024
0.02x
Sep 2024
0.03x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
7.70x
TTM operating cash flow over LongTermDebt as filed 2026-06-30 (includes the current portion)
Cash flow to debt TRT
FY Jun 2026
7.70x
FY Jun 2025
0.54x
FY Jun 2024
3.11x
FY Jun 2023
6.00x
FY Jun 2022
1.57x
Jun 2026
7.70x
Mar 2026
3.21x
Dec 2025
2.04x
Sep 2025
5.08x
Jun 2025
0.54x
Mar 2025
1.69x
Dec 2024
2.05x
Sep 2024
0.91x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-0.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity TRT
FY Jun 2026
-0.1%
FY Jun 2025
-0.1%
FY Jun 2024
+3.5%
FY Jun 2023
+5.4%
FY Jun 2022
+9.0%
Jun 2026
-0.1%
Mar 2026
+1.0%
Dec 2025
-0.3%
Sep 2025
+0.8%
Jun 2025
-0.1%
Mar 2025
+0.1%
Dec 2024
+1.8%
Sep 2024
+1.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-0.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets TRT
FY Jun 2026
-0.1%
FY Jun 2025
-0.1%
FY Jun 2024
+2.5%
FY Jun 2023
+3.6%
FY Jun 2022
+5.9%
Jun 2026
-0.1%
Mar 2026
+0.8%
Dec 2025
-0.3%
Sep 2025
+0.6%
Jun 2025
-0.1%
Mar 2025
+0.0%
Dec 2024
+1.4%
Sep 2024
+1.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate 59%, not meaningful
Return on invested capital TRT
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
+3.4%
FY Jun 2023
+7.4%
FY Jun 2022
+8.3%
Jun 2026
n/a
Mar 2026
+1.6%
Dec 2025
n/a
Sep 2025
+0.5%
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
+1.5%
Sep 2024
+3.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-0.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed TRT
FY Jun 2026
-0.5%
FY Jun 2025
+0.7%
FY Jun 2024
+3.3%
FY Jun 2023
+6.9%
FY Jun 2022
+7.7%
Jun 2026
-0.5%
Mar 2026
+1.5%
Dec 2025
+0.8%
Sep 2025
+0.5%
Jun 2025
+0.7%
Mar 2025
+0.4%
Dec 2024
+1.6%
Sep 2024
+3.7%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
527.00x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing TRT
FY Jun 2026
1,232.00x
FY Jun 2025
n/a
FY Jun 2024
12.69x
FY Jun 2023
6.50x
FY Jun 2022
3.73x
Jun 2026
1,232.00x
Mar 2026
96.33x
Dec 2025
3,816,170,114,277,965,824.00x
Sep 2025
59.30x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
41.50x
Sep 2024
21.31x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$33.7M
market value at close 2026-10-27 on 2026-09-01 shares, plus LongTermDebt as filed 2026-06-30 (includes the current portion), minus cash 2026-06-30
Enterprise value TRT
FY Jun 2026
$103.6M
FY Jun 2025
$1.5M
FY Jun 2024
$3.8M
FY Jun 2023
$3.6M
FY Jun 2022
$2.4M
Jun 2026
$103.6M
Mar 2026
$38.1M
Dec 2025
$17.0M
Sep 2025
$1.1M
Jun 2025
$1.5M
Mar 2025
$2.4M
Dec 2024
$2.8M
Sep 2024
$3.7M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.1%
TTM free cash flow over market value at close 2026-10-27
FCF yield TRT
FY Jun 2026
+1.4%
FY Jun 2025
-5.1%
FY Jun 2024
+16.8%
FY Jun 2023
+36.7%
FY Jun 2022
+7.5%
Jun 2026
+1.4%
Mar 2026
+0.4%
Dec 2025
+0.5%
Sep 2025
+17.3%
Jun 2025
-5.1%
Mar 2025
+3.9%
Dec 2024
+7.8%
Sep 2024
+2.6%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing TRT
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
TRT ranks highest on financial health (87th percentile) and growth (85th), and lowest on risk and compliance (16th), among Semiconductors & Electronics peers.
Profitability
44
Inputs
Return on equity-0.1% · 43 pct, sector of 154
Return on assets-0.1% · 47 pct, sector of 171
Return on invested capitaleffective tax rate 59%, not meaningful
Return on capital employed-0.5% · 42 pct, sector of 155
Financial health
87
Inputs
Debt to equity0.01x · 81 pct, sector of 152
Cash flow to debt7.70x · 93 pct, sector of 136
Growth
85
Inputs
Revenue growth, YoY+71.6% · 85 pct, sector of 194
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
28
Inputs
Net Form 4 buying (codes P and S), 180d-$2.5M · 56 pct, sector of 147
Insider buyers, 180d0 · 0 pct, sector of 151
Institutional and government
20
Inputs
Funds adding, latest quarter24 · 20 pct, sector of 184
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
16
Inputs
Short interest, % of float+14.3% · 16 pct, sector of 221
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
TRT filings, in plain words
Are Trio-tech International insiders buying or selling TRT?
In the 180 days to 2026-10-28, Trio-tech International insiders were net sellers, a net $2.5M across purchases and sales reported on Form 4, by 3 sellers.
Are there planned insider sales of TRT?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $573.5K of stock; the latest, by HOROWITZ RICHARD M, was filed 2026-09-28.
Read the full summary
In the 180 days to 2026-10-28, Trio-tech International insiders were net sellers of TRT, a net $2.5M across purchases and sales reported on Form 4 by 3 sellers. None of the 10 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $573.5K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.